354 related articles for article (PubMed ID: 30717946)
1. Psoas Muscle Density in Combination with Model for End-Stage Liver Disease Score Can Improve Survival Predictability in Transjugular Intrahepatic Portosystemic Shunts.
Shoreibah MG; Mahmoud K; Aboueldahab NA; Vande Lune P; Massoud M; Bae S; El Khudari H; Gunn AJ; Abdel Aal AK
J Vasc Interv Radiol; 2019 Feb; 30(2):154-161. PubMed ID: 30717946
[TBL] [Abstract][Full Text] [Related]
2. Prediction of Patient Survival with Psoas Muscle Density Following Transjugular Intrahepatic Portosystemic Shunts: A Retrospective Cohort Study.
Zhang B; Cai W; Gao F; Lin X; Qian T; Gu K; Song B; Chen T
Med Sci Monit; 2022 Jan; 28():e934057. PubMed ID: 35031594
[TBL] [Abstract][Full Text] [Related]
3. Muscle Gain after Transjugular Intrahepatic Portosystemic Shunt Creation: Time Course and Prognostic Implications for Survival in Cirrhosis.
Jahangiri Y; Pathak P; Tomozawa Y; Li L; Schlansky BL; Farsad K
J Vasc Interv Radiol; 2019 Jun; 30(6):866-872.e4. PubMed ID: 31053265
[TBL] [Abstract][Full Text] [Related]
4. Reversal of sarcopenia predicts survival after a transjugular intrahepatic portosystemic stent.
Tsien C; Shah SN; McCullough AJ; Dasarathy S
Eur J Gastroenterol Hepatol; 2013 Jan; 25(1):85-93. PubMed ID: 23011041
[TBL] [Abstract][Full Text] [Related]
5. Psoas Muscle Density Predicts Occurrences of Hepatic Encephalopathy in Patients Receiving Transjugular Intrahepatic Portosystemic Shunts within 1 year.
Cai W; Lin H; Qi R; Lin X; Zhao Y; Chen W; Huang Z
Cardiovasc Intervent Radiol; 2022 Jan; 45(1):93-101. PubMed ID: 34523022
[TBL] [Abstract][Full Text] [Related]
6. Prognostic capability of different liver disease scoring systems for prediction of early mortality after transjugular intrahepatic portosystemic shunt creation.
Gaba RC; Couture PM; Bui JT; Knuttinen MG; Walzer NM; Kallwitz ER; Berkes JL; Cotler SJ
J Vasc Interv Radiol; 2013 Mar; 24(3):411-20, 420.e1-4; quiz 421. PubMed ID: 23312989
[TBL] [Abstract][Full Text] [Related]
7. Within-patient temporal variance in MELD score and impact on survival prediction after TIPS creation.
Gaba RC; Shah KD; Couture PM; Parvinian A; Minocha J; Knuttinen MG; Bui JT
Ann Hepatol; 2013; 12(5):797-802. PubMed ID: 24018498
[TBL] [Abstract][Full Text] [Related]
8. Albumin-bilirubin grade versus MELD score for predicting survival after transjugular intrahepatic portosystemic shunt (TIPS) creation.
Ronald J; Wang Q; Choi SS; Suhocki PV; Hall MD; Smith TP; Kim CY
Diagn Interv Imaging; 2018 Mar; 99(3):163-168. PubMed ID: 29154015
[TBL] [Abstract][Full Text] [Related]
9. Sarcopenia Is Associated With Development of Acute-on-Chronic Liver Failure in Decompensated Liver Cirrhosis Receiving Transjugular Intrahepatic Portosystemic Shunt.
Praktiknjo M; Clees C; Pigliacelli A; Fischer S; Jansen C; Lehmann J; Pohlmann A; Lattanzi B; Krabbe VK; Strassburg CP; Arroyo V; Merli M; Meyer C; Trebicka J
Clin Transl Gastroenterol; 2019 Apr; 10(4):e00025. PubMed ID: 30939488
[TBL] [Abstract][Full Text] [Related]
10. Survival after elective transjugular intrahepatic portosystemic shunt creation: prediction with model for end-stage liver disease score.
Ferral H; Gamboa P; Postoak DW; Albernaz VS; Young CR; Speeg KV; McMahan CA
Radiology; 2004 Apr; 231(1):231-6. PubMed ID: 14990811
[TBL] [Abstract][Full Text] [Related]
11. Relative Sarcopenia With Excess Adiposity Predicts Survival After Transjugular Intrahepatic Portosystemic Shunt Creation.
Ronald J; Bozdogan E; Zaki IH; Kappus MR; Choi SS; Martin JG; Suhocki PV; Smith TP; Kim CY; Bashir MR
AJR Am J Roentgenol; 2020 Jan; 214(1):200-205. PubMed ID: 31670594
[No Abstract] [Full Text] [Related]
12. Older patient age may predict early mortality after transjugular intrahepatic portosystemic shunt creation in individuals at intermediate risk.
Parvinian A; Shah KD; Couture PM; Minocha J; Knuttinen MG; Bui JT; Gaba RC
J Vasc Interv Radiol; 2013 Jul; 24(7):941-6. PubMed ID: 23707226
[TBL] [Abstract][Full Text] [Related]
13. Prediction of Mortality and Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt Placement: Baseline and Longitudinal Body Composition Measurement.
Tuifua TS; Kapoor B; Partovi S; Shah SN; Bullen JA; Enders J; Laique S; Levitin A; Gadani S
J Vasc Interv Radiol; 2024 May; 35(5):648-657.e1. PubMed ID: 38244917
[TBL] [Abstract][Full Text] [Related]
14. Increase of radiologically determined muscle area in patients with liver cirrhosis after transjugular intrahepatic portosystemic shunt.
March C; Thormann M; Geipel S; Sowa JP; Barajas Ordonez F; Pech M; Omari J; Lemmer P
Sci Rep; 2023 Oct; 13(1):17092. PubMed ID: 37816875
[TBL] [Abstract][Full Text] [Related]
15. Early-Recurrent Overt Hepatic Encephalopathy Is Associated with Reduced Survival in Cirrhotic Patients after Transjugular Intrahepatic Portosystemic Shunt Creation.
Zuo L; Lv Y; Wang Q; Yin Z; Wang Z; He C; Guo W; Niu J; Bai W; Li K; Yu T; Yuan X; Chen H; Liu H; Xia D; Wang E; Luo B; Li X; Yuan J; Han N; Nie Y; Fan D; Han G
J Vasc Interv Radiol; 2019 Feb; 30(2):148-153.e2. PubMed ID: 30638778
[TBL] [Abstract][Full Text] [Related]
16. Transjugular intrahepatic portosystemic shunts in liver transplant recipients for management of refractory ascites: clinical outcome.
Saad WE; Darwish WM; Davies MG; Waldman DL
J Vasc Interv Radiol; 2010 Feb; 21(2):218-23. PubMed ID: 20123207
[TBL] [Abstract][Full Text] [Related]
17. MELD score is better than Child-Pugh score in predicting 3-month survival of patients undergoing transjugular intrahepatic portosystemic shunt.
Salerno F; Merli M; Cazzaniga M; Valeriano V; Rossi P; Lovaria A; Meregaglia D; Nicolini A; Lubatti L; Riggio O
J Hepatol; 2002 Apr; 36(4):494-500. PubMed ID: 11943420
[TBL] [Abstract][Full Text] [Related]
18. Applying the original model for end-stage liver disease score rather than the model for end-stage liver disease-Na score for risk stratification prior to transjugular intrahepatic portosystemic shunt procedures.
Lee BT; Yang AH; Urban S; Kim KY; Ter-Oganesyan R; Yuan L; Han HH; Khemichian S; Kahn JA; Kim B
Eur J Gastroenterol Hepatol; 2021 Apr; 33(4):541-546. PubMed ID: 32398491
[TBL] [Abstract][Full Text] [Related]
19. Comparison of MELD, Child-Pugh, and Emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting.
Schepke M; Roth F; Fimmers R; Brensing KA; Sudhop T; Schild HH; Sauerbruch T
Am J Gastroenterol; 2003 May; 98(5):1167-74. PubMed ID: 12809844
[TBL] [Abstract][Full Text] [Related]
20. No Increased Mortality After TIPS Compared with Serial Large Volume Paracenteses in Patients with Higher Model for End-Stage Liver Disease Score and Refractory Ascites.
Ronald J; Rao R; Choi SS; Kappus M; Martin JG; Sag AA; Pabon-Ramos WM; Suhocki PV; Smith TP; Kim CY
Cardiovasc Intervent Radiol; 2019 May; 42(5):720-728. PubMed ID: 30603968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
